Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Edwards

Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion

Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.

Investors Business Daily

Is Edwards Lifesciences Stock Underperforming the S&P 500?

Edwards Lifesciences has recently underperformed the broader S&P 500, yet analysts remain moderately optimistic about the stock's potential.

Barchart

Edwards Lifesciences Outlines Vision For Growth At Investor Conference

Edwards Lifesciences outlines 2025 growth strategy, emphasizing innovations in TAVR and TMTT therapies, with a projected sales growth of 8%-10% and expanded patient care.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Edwards Skids On Weak Expectations For Its Bread-And-Butter Moneymaker

Edwards Lifesciences stock fell Friday after the company said its TAVR segment will face numerous challenges in the fourth quarter.

Investors Business Daily

Edwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker

Edwards Lifesciences stock plummeted Thursday after the medtech cut its outlook for TAVR sales following a mixed second-quarter report.

Investors Business Daily

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion.

Investors Business Daily

Edwards Lifesciences Sinks Despite An Earnings Beat, Outlook Increase

Edwards Lifesciences stock fell late Wednesday after the medtech company reported Q2 earnings, narrowly topping profit and revenue expectations.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Edwards Lifesciences Surges As Signs Point To 'Green Shoots Around The Corner'

There are signs of green shoots around the corner for Edwards Lifesciences, an analyst said Wednesday as EW stock surged.

Investors Business Daily

Secrets, legends and new places: six influencers talk about what makes Newcastle great

Looking for some new places to explore and fun things to do in and around Newcastle this year?

Newcastle Herald

Edwards Plummets After Slashing Profit Guidance As Challenges Mount In The U.S.

Edwards slashed its profit outlook, leading EW stock to plummet Friday amid continued hospital staffing and exchange-rate challenges.

Investors Business Daily

Food Bites: Myrtle & Stone cafe helps Wollombi flood appeal

Plus, party time at Modus Merewether, LC Deli, FogHorn Brewery's final pop-up at the footy, Bottomless Bird, and it's your last chance to buy tickets to Thursday night's Four Pillars Gin Dinner at The Edwards.

Newcastle Herald

Distillery cans award-winning King Edward vodka as a summer spritz

Elsham Wold Distillery launches two flavours in on-trend ready-to-drink format

Birmingham Post

Food Bites: Crystalbrook Kingsley in Newcastle to host An Evening of Dreaming

The Roundhouse has a new executive chef, meet Paterson Tavern's new owners, and more foodie news.

Newcastle Herald

Abbott Laboratories vs. Edwards Lifesciences: Which Medical Device Stock is a Better Investment?

The growing prevalence of chronic diseases, an increasing elderly population, and rapid adoption of advanced medical technologies are driving the growth of the medical device industry. The industry is expected to witness solid growth over the long term, to the benefit of the stocks of medical device companies Abbott (ABT)…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Newcastle Herald

Silverchair's Chris Joannou sells The Edwards site for over $4 million

The sale will not affect the day-to-day running of the venue.

Newcastle Herald

Food Bites: Chinese cooking is a labour of love for The Edwards' head chef Jess Brooks

She will be cooking up a storm at Sunday night's Chinese BANGquet. Plus, Pampa Flame, Maitland Taste Festival, a cookbook to give away, and more foodie news.

Investors Business Daily

How Too-Bullish Profit Expectations Caused Edwards Lifesciences To Crumble

Edwards Lifesciences topped Wall Street's first-quarter views on Tuesday, but EW stock fell in after-hours action.

Investors Business Daily

Dow Jones Rallies Ahead Of Powell Comments; Tesla Surges 11% On Earnings

The Dow Jones Industrial Average rallied 300 points Thursday ahead of Fed Chief Powell's comments. Tesla surged 11% on earnings results.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rises, But Netflix Crashes 34% On Earnings; Tesla Earnings Due

The Dow Jones Industrial Average rose 200 points Wednesday, but Netflix crashed more than 35% on earnings. Tesla earnings are due late.

Investors Business Daily

Dow Jones Rises As Earnings Season Continues; Netflix Earnings On Deck

The Dow Jones Industrial Average rose Tuesday, as earnings season continues. Netflix earnings are due out after the close.

Investors Business Daily

Dow Jones Futures: What To Do After Monday's Stock Market Fall; Netflix, Tesla Earnings Ahead

Dow Jones futures were higher after Monday's stock market fall. Netflix and Tesla earnings are due out later this week.

Investors Business Daily

IBD Stock Of The Day Edwards Lifesciences Is Eyeing $15 Billion — And A Buy Point

Edwards Lifesciences is the IBD Stock Of The Day as the easing Covid pandemic allows for bullish growth in TAVR procedures in the U.S.

Investors Business Daily

Pfizer Stock, Raytheon Lead 5 Stocks Near Buy Points

Pfizer and Raytheon are among 5 stocks near buy points that offer protection from geopolitics and aggressive rate-hikes.

Investors Business Daily

Heart Valve Maker Eyes Breakout After Getting An FDA Approval

As heart valve maker Edwards Lifesciences wins a new FDA approval, the stock looks to pump out a fresh breakout.

Benzinga

FDA Approves Edwards Lifesciences' Resilia Valve For Mitral Replacement Surgery

The FDA has approved Edwards Lifesciences Corp's (NYSE: EW) Mitris Resilia valve, a tissue valve replacement specifically designed for the heart's mitral position.

1 2

People

Jerome Powell

2,260 stories

Mangeet Kaur BounsMangeet

Margaret Kaczor Andrew

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.